• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皱缩的片段平面景观:3D 环丁烷片段库的设计与合成。

Puckering the Planar Landscape of Fragments: Design and Synthesis of a 3D Cyclobutane Fragment Library.

机构信息

Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands.

Department of Chemistry, University of York, YO10 5DD, York, UK.

出版信息

ChemMedChem. 2022 May 4;17(9):e202200113. doi: 10.1002/cmdc.202200113. Epub 2022 Mar 30.

DOI:10.1002/cmdc.202200113
PMID:35277937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9315009/
Abstract

Fragment-based drug discovery (FBDD) has a growing need for unique screening libraries. The cyclobutane moiety was identified as an underrepresented yet attractive three-dimensional (3D) scaffold. Synthetic strategies were developed via a key 3-azido-cyclobutanone intermediate, giving potential access to a range of functional groups with accessible growth vectors. A focused set of 33 novel 3D cyclobutane fragments was synthesised, comprising three functionalities: secondary amines, amides, and sulfonamides. This library was designed using Principal Component Analysis (PCA) and an expanded version of the rule of three (RO3), followed by Principal Moment of Inertia (PMI) analysis to achieve both chemical diversity and high 3D character. Cis and trans ring isomers of library members were generated to maximise the shape diversity obtained, while limiting molecular complexity through avoiding enantiomers. Property analyses of the cyclobutane library indicated that it fares favourably against existing synthetic 3D fragment libraries in terms of shape and physicochemical properties.

摘要

基于片段的药物发现(FBDD)对独特的筛选库有越来越大的需求。环丁烷部分被确定为一个代表性不足但有吸引力的三维(3D)支架。通过关键的 3-叠氮环丁酮中间体开发了合成策略,为一系列具有可接近生长矢量的官能团提供了潜在的途径。合成了一组 33 种新型的 3D 环丁烷片段,包括三种官能团:仲胺、酰胺和磺酰胺。该库使用主成分分析(PCA)和扩展的三规则(RO3)设计,然后进行主惯性矩(PMI)分析,以实现化学多样性和高 3D 特征。库成员的顺式和反式环异构体被生成以最大化获得的形状多样性,同时通过避免对映体来限制分子复杂性。对环丁烷文库的性质分析表明,它在形状和物理化学性质方面优于现有的合成 3D 片段文库。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f6/9315009/5f85cb78035f/CMDC-17-0-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f6/9315009/6ef6f4f0326f/CMDC-17-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f6/9315009/c6a82092b80d/CMDC-17-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f6/9315009/1c7c5f2123ca/CMDC-17-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f6/9315009/1b6431cc893f/CMDC-17-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f6/9315009/1a6c44d3adac/CMDC-17-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f6/9315009/5f85cb78035f/CMDC-17-0-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f6/9315009/6ef6f4f0326f/CMDC-17-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f6/9315009/c6a82092b80d/CMDC-17-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f6/9315009/1c7c5f2123ca/CMDC-17-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f6/9315009/1b6431cc893f/CMDC-17-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f6/9315009/1a6c44d3adac/CMDC-17-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f6/9315009/5f85cb78035f/CMDC-17-0-g008.jpg

相似文献

1
Puckering the Planar Landscape of Fragments: Design and Synthesis of a 3D Cyclobutane Fragment Library.皱缩的片段平面景观:3D 环丁烷片段库的设计与合成。
ChemMedChem. 2022 May 4;17(9):e202200113. doi: 10.1002/cmdc.202200113. Epub 2022 Mar 30.
2
Escape from planarity in fragment-based drug discovery: A physicochemical and 3D property analysis of synthetic 3D fragment libraries.基于片段的药物发现中的逃离平面性:合成 3D 片段文库的物理化学和 3D 性质分析。
Drug Discov Today Technol. 2020 Dec;38:77-90. doi: 10.1016/j.ddtec.2021.05.001. Epub 2021 Jun 17.
3
Escape from planarity in fragment-based drug discovery: A synthetic strategy analysis of synthetic 3D fragment libraries.基于片段的药物发现中的逃离平面性:合成 3D 片段文库的合成策略分析。
Drug Discov Today. 2022 Sep;27(9):2484-2496. doi: 10.1016/j.drudis.2022.05.021. Epub 2022 May 27.
4
An Automated, Open-Source Workflow for the Generation of (3D) Fragment Libraries.一种用于生成(3D)片段库的自动化开源工作流程。
ACS Med Chem Lett. 2023 May 2;14(5):583-590. doi: 10.1021/acsmedchemlett.2c00503. eCollection 2023 May 11.
5
Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery.将药物化学扩展到三维空间:金属片段作为基于片段药物发现的三维支架
Chem Sci. 2019 Dec 12;11(5):1216-1225. doi: 10.1039/c9sc05586j.
6
Towards systematic exploration of chemical space: building the fragment library module in molecular property diagnostic suite.迈向化学空间的系统探索:构建分子性质诊断套件中的片段库模块。
Mol Divers. 2023 Jun;27(3):1459-1468. doi: 10.1007/s11030-022-10506-5. Epub 2022 Aug 4.
7
How Size Matters: Diversity for Fragment Library Design.大小很重要:片段文库设计的多样性。
Molecules. 2019 Aug 5;24(15):2838. doi: 10.3390/molecules24152838.
8
Fragment-Based Drug Design of Selective HDAC6 Inhibitors.选择性组蛋白去乙酰化酶6(HDAC6)抑制剂的基于片段的药物设计
Methods Mol Biol. 2021;2266:155-170. doi: 10.1007/978-1-0716-1209-5_9.
9
Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia.片段库的设计原则:最大化从制药行业基于片段的药物发现(FBDD)项目中获得的知识价值以应用于学术界。
J Med Chem. 2016 Sep 22;59(18):8189-206. doi: 10.1021/acs.jmedchem.6b00197. Epub 2016 May 16.
10
Using DNA-encoded libraries of fragments for hit discovery of challenging therapeutic targets.利用片段的 DNA 编码文库进行具有挑战性的治疗靶目标的命中发现。
Expert Opin Drug Discov. 2024 Jun;19(6):725-740. doi: 10.1080/17460441.2024.2354287. Epub 2024 May 16.

引用本文的文献

1
Difluoromethylene cyclobutyl sulfonium salts: versatile reagents for chemodivergent synthesis of difluoroalkylated cyclobutenes and cyclobutanes.二氟亚甲基环丁基锍盐:用于化学发散合成二氟烷基化环丁烯和环丁烷的多功能试剂。
Chem Sci. 2025 Aug 12. doi: 10.1039/d5sc05409e.
2
Screening Enamine Fragments Library in the Quest for Novel SOS2 Inhibitors: Pharmacophore Modelling, Molecular Docking, MMGBSA Calculations, and MD Simulation.在寻找新型SOS2抑制剂中筛选烯胺片段库:药效团建模、分子对接、MMGBSA计算和分子动力学模拟
J Pharm Bioallied Sci. 2025 Jun;17(Suppl 2):S1894-S1899. doi: 10.4103/jpbs.jpbs_534_25. Epub 2025 Jun 18.

本文引用的文献

1
Fragment-to-Lead Medicinal Chemistry Publications in 2020.2020 年的碎片至先导药物化学出版物。
J Med Chem. 2022 Jan 13;65(1):84-99. doi: 10.1021/acs.jmedchem.1c01803. Epub 2021 Dec 20.
2
Escape from planarity in fragment-based drug discovery: A physicochemical and 3D property analysis of synthetic 3D fragment libraries.基于片段的药物发现中的逃离平面性:合成 3D 片段文库的物理化学和 3D 性质分析。
Drug Discov Today Technol. 2020 Dec;38:77-90. doi: 10.1016/j.ddtec.2021.05.001. Epub 2021 Jun 17.
3
C-H functionalisation tolerant to polar groups could transform fragment-based drug discovery (FBDD).
耐受极性基团的碳-氢官能化能够变革基于片段的药物发现(FBDD)。
Chem Sci. 2021 Sep 1;12(36):11976-11985. doi: 10.1039/d1sc03563k. eCollection 2021 Sep 22.
4
Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design.苯环的生物电子等排体:在先导化合物优化和药物设计中的近期策略性应用
J Med Chem. 2021 Oct 14;64(19):14046-14128. doi: 10.1021/acs.jmedchem.1c01215. Epub 2021 Sep 30.
5
Emergent synthetic methods for the modular advancement of sp-rich fragments.用于富sp片段模块化推进的紧急合成方法。
Chem Sci. 2021 Mar 2;12(13):4646-4660. doi: 10.1039/d1sc00161b.
6
Fragment-based drug discovery: opportunities for organic synthesis.基于片段的药物发现:有机合成的机遇
RSC Med Chem. 2020 Dec 24;12(3):321-329. doi: 10.1039/d0md00375a.
7
Put a ring on it: application of small aliphatic rings in medicinal chemistry.为其戴上一环:小脂肪族环在药物化学中的应用
RSC Med Chem. 2021 Jan 7;12(4):448-471. doi: 10.1039/d0md00370k. eCollection 2021 Apr 28.
8
What's in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications.名称的含义是什么?利用 INN 出版物了解药物命名法和药物化学趋势。
J Med Chem. 2021 Apr 22;64(8):4410-4429. doi: 10.1021/acs.jmedchem.1c00181. Epub 2021 Apr 13.
9
Fragment-to-Lead Medicinal Chemistry Publications in 2019.2019 年的碎片到先导药物化学出版物。
J Med Chem. 2020 Dec 24;63(24):15494-15507. doi: 10.1021/acs.jmedchem.0c01608. Epub 2020 Nov 23.
10
Bromo-Cyclobutenaminones as New Covalent UDP--Acetylglucosamine Enolpyruvyl Transferase (MurA) Inhibitors.溴代环丁烯胺酮作为新型共价UDP - N - 乙酰葡糖胺烯醇丙酮酸转移酶(MurA)抑制剂
Pharmaceuticals (Basel). 2020 Nov 3;13(11):362. doi: 10.3390/ph13110362.